News

New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership

HAYWARD, Calif., May 01, 2023--Pulse Biosciences, Inc., a company leveraging its novel and proprietary nanosecond pulsed field ablation (nsPFA™) technology and proprietary CellFX System® for the treatment of atrial fibrillation, today...

-If approved, CAMZYOS would be the first cardiac myosin inhibitor in Europe that specifically targets the source of obstructive HCM -Recommendation based on positive Phase 3 EXPLORER-HCM and VALOR-HCM trials demonstrating benefit in patients...

OXFORD, England, April 26, 2023 /--Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been granted FDA Breakthrough Device Status for its AI-enhanced platform for detecting cardiac...

LILLESAND, Norway, April 17, 2023-- A new Norwegian study shows that atrial fibrillation can easily be revealed with self-testing. Atrial fibrillation is a common heart rhythm disorder, and its incidence is increasing. One...

Expansion leverages a custom module to help health systems identify patients eligible for lifesaving therapy

Barcelona, Spain – 18 April 2023: A novel software tool set to improve the management of elderly atrial fibrillation patients with multiple conditions is being designed by the EU-funded and ESC-coordinated EHRA-PATHS consortium. The...

Series of Clinical Studies Highlight Advantages of ECGenius System and CARDIALYTICS Suite of Algorithms

Barcelona, Spain – 17 April 2023: High power electric vehicle chargers are safe for patients with pacemakers and defibrillators, according to a study published today in EP Europace,1 a journal of the European Society of Cardiology...